封面
市场调查报告书
商品编码
1617143

Peri -到 2030 年的植体炎治疗市场预测:按治疗类型、原因类型、植入类型、设备类型、最终用户和地区进行的全球分析

Peri-Implantitis Treatment Market Forecasts to 2030 - Global Analysis By Treatment Type (Non-Surgical Treatments, Surgical Treatments, Combination Treatments and Other Treatment Types), Cause Type, Implant Type, Device Type, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据,2024 年全球植体植入炎治疗市场规模为 11 亿美元,预计预测期内复合年增长率为 10.7%,到 2030 年将达到 21 亿美元。

植体周围植入的治疗包括控制植入周围的发炎和感染。治疗选择取决于症状的严重程度,但通常包括非手术方法,例如机械清洗和消毒清洗以减少细菌负荷。更严重的病例需要手术干预,例如皮瓣手术,以进入和清洗更深的区域。抗生素和适当的口腔卫生对于预防復发和长期植入成功至关重要。

根据 NCBI 的数据,在美国平均 2 年追踪期间,患者层面的植入周围炎盛行率为 34.0%,植入层面的盛行率为 21%。

增加植入的使用

人工植牙使用的增加极大地推动了市场的发展。随着越来越多的人选择人工植牙来替代牙齿,对常见併发症植体周围植入的有效治疗的需求不断增长。因此,诊断技术和治疗方案的进步,包括非手术干预和微创手术,正在推动市场成长。对长期植入成功的关注进一步增加了对专门植体周围植入治疗的需求。

缺乏熟练的专家

市面上缺乏熟练的专家会对患者的治疗结果和整体治疗效果产生负面影响。由于专业知识有限,植入的诊断和治疗可能会延迟或不充分,从而导致更高的植入失败率和更长的恢復时间。这种短缺也阻碍了技术创新,限制了先进治疗的获得,并增加了现有专家的负担,导致等待时间更长和治疗可用性降低。

民众口腔卫生意识

民众对口腔卫生意识的提高正在对市场产生正面影响。随着越来越多的人意识到口腔卫生的重要性,尤其是植入周围的口腔卫生,预防植体周围植入已成为人们关注的焦点。关于适当护理、卫生习惯和早期发现的教育宣传活动有助于改善植体周围植入的预防和管理。这种意识的提高推动了对有效治疗方案的需求,并促进了长期植入的成功。

治疗费用高

市面上高昂的治疗费用是许多患者治疗的主要障碍。先进的手术,包括外科手术和专门治疗,通常需要昂贵的设备和专业知识,这增加了成本。这种经济负担限制了患者获得所需治疗的机会,并可能导致他们的医疗状况恶化和植入失败。结果,治疗被推迟或放弃,导致长期健康併发症恶化并增加整体医疗费用。

COVID-19 的影响:

COVID-19 大流行导致选择性牙科手术(包括植入相关治疗)的延误,并严重扰乱了植体周围植入的治疗市场。锁门和保持社交距离的措施导致就诊人数减少、人员短缺以及对紧急护理的关注,从而延迟了植体周围植入的诊断和治疗。此外,财务不安全和对非必要服务的限制导致成本增加和获得专门护理的机会有限,影响整体治疗结果。

预计钛植入市场在预测期内将成为最大的市场

由于人工植牙的普及,钛植入预计将在预测期内占据最大的市场占有率。钛的生物相容性和耐腐蚀性使其成为植入的首选材料。植入设计、表面改性和治疗方法的进步正在推动市场扩张,重点是提高长期植入成功率并减少感染和骨质流失等併发症。

牙科诊所预计在预测期内复合年增长率最高

预计牙科诊所产业在预测期内将呈现最高的复合年增长率。牙科诊所越来越多地采用先进的诊断工具和治疗技术,例如雷射疗法、抗菌药物和再生手术,来控制植体周围植入。人们对植入失败风险的认识不断提高,以及对有效干预措施的需求不断增加,这推动了对这些环境下专门治疗的需求,从而推动了市场的成长。

比最大的地区

由于人工植牙数量的增加,预计北美地区在预测期内将占据最大的市场占有率。雷射疗法和再生技术等诊断和治疗技术的进步正在推动市场发展。该地区完善的医疗保健基础设施可支援市场扩张以及对牙科治疗服务的高需求,使该地区成为植体周围植入治疗创新的关键中心。

复合年增长率最高的地区:

由于口腔健康问题日益严重、意识不断提高以及支持性医疗保健政策,亚太地区预计将在预测期内实现最高成长率。该地区的龋齿和牙周病患病率高得惊人,尤其是老年人。提高口腔卫生意识对于推动植体周围植入治疗的需求至关重要。此外,有利的政府政策和医疗基础设施的进步也有助于市场扩张。

免费客製化服务:

订阅此报告的客户可以存取以下免费自订选项之一:

  • 公司简介
    • 其他市场参与者的综合分析(最多 3 家公司)
    • 主要企业SWOT分析(最多3家企业)
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率(註:基于可行性检查)
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球植体周围植入治疗市场:依治疗类型

  • 非手术治疗
    • 机械清创术
    • 雷射治疗
    • 抗菌治疗
    • 区域给药
  • 手术治疗
    • 皮瓣手术
    • 骨移植
    • 引导骨再生(GBR)
  • 复杂的治疗
  • 其他类型的治疗

第六章全球植体周围植入治疗市场:依原因分类

  • 细菌感染
  • 咬合面负荷过大
  • 植入设计或放置问题
  • 生物

第七章全球植入治疗市场:依植入类型分类

  • 钛植入
  • 氧化锆植入
  • 陶瓷植入
  • 羟磷石灰涂层
  • 聚合物植入

第八章全球植入周围炎治疗市场:依设备类型

  • 超音波设备
  • 雷射
  • 骨移植材料
  • 手术器械

第九章全球植体周围植入治疗市场:依最终用户分类

  • 牙医诊所
  • 医院
  • 日间手术中心 (ASC)
  • 其他最终用户

第十章全球植入周围炎治疗市场:按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章 公司概况

  • Pfizer Inc.
  • Cadila Pharmaceuticals
  • R N. Laboratories
  • Triveni Chemicals
  • Arthrex
  • Zimmer Biomet Dental
  • Stryker
  • Smith & Nephew
  • Danaher
  • 3M
  • Meyer Dental Laboratory
  • Cochlear Limited
  • Medtronic
  • Bicon Dental Implants
  • Cendres+Metaux
  • Straumann AG
  • Fotona
Product Code: SMRC28021

According to Stratistics MRC, the Global Peri-Implantitis Treatment Market is accounted for $1.1 billion in 2024 and is expected to reach $2.1 billion by 2030 growing at a CAGR of 10.7% during the forecast period. Peri-implantitis treatment involves managing inflammation and infection around a dental implant, typically affecting the tissues surrounding the implant. Treatment options vary depending on the severity of the condition but often include non-surgical methods like mechanical debridement (cleaning) and antiseptic rinses to reduce bacterial load. In more severe cases, surgical interventions such as flap surgery may be necessary to access and clean deeper areas. Antibiotics and proper oral hygiene are essential for preventing recurrence and ensuring long-term implant success.

According to NCBI, the prevalence of peri-implantitis was 34.0% on the patient level and 21% on the implant level over an average follow-up of 2 years in the U.S.

Market Dynamics:

Driver:

Increasing usage of dental implants

The increasing use of dental implants has significantly boosted the market. As more people opt for dental implants for tooth replacement, the demand for effective treatments for peri-implantitis, a common complication, rises. This has led to advancements in diagnostic techniques and therapeutic options, including non-surgical interventions and minimally invasive procedures, driving growth in the market. The focus on long-term implant success further enhances the demand for specialized peri-implantitis treatments.

Restraint:

Shortage of skilled specialists

The shortage of skilled specialists in the market negatively impacts patient outcomes and the overall effectiveness of treatments. With limited expertise, the diagnosis and management of peri-implantitis may be delayed or inadequate, leading to higher failure rates of implants and prolonged recovery times. This shortage also hampers innovation, restricts access to advanced care, and increases the burden on existing specialists, resulting in longer waiting times and reduced treatment availability.

Opportunity:

Public awareness of oral hygiene

Rising public awareness of oral hygiene has positively impacted the market. As more individuals recognize the importance of maintaining oral health, especially around dental implants, there is an increased focus on preventing peri-implantitis. Educational campaigns on proper care, hygiene practices, and early detection contribute to better prevention and management of the condition. This growing awareness drives demand for effective treatment options and promotes long-term implant success.

Threat:

High treatment costs

High treatment costs in the market pose a significant barrier to access for many patients. The advanced procedures, including surgical interventions and specialized care, often require expensive equipment and expertise, driving up costs. This financial burden can limit patient access to necessary treatments, potentially leading to worsened conditions or implant failure. As a result, individuals may delay or forgo treatment, exacerbating long-term health complications and increasing overall healthcare costs.

Covid-19 Impact:

The COVID-19 pandemic significantly disrupted the peri-implantitis treatment market by causing delays in elective dental procedures, including implant-related treatments. Lockdowns and social distancing measures led to reduced patient visits, staff shortages, and a focus on urgent care, slowing down the diagnosis and management of peri-implantitis. Additionally, financial uncertainties and restrictions on non-essential services led to increased costs and limited access to specialized care, affecting overall treatment outcomes.

The titanium implants segment is expected to be the largest during the forecast period

The titanium implants segment is expected to account for the largest market share during the projection period due to the increasing prevalence of dental implant procedures. Titanium's biocompatibility and resistance to corrosion make it a preferred material for implants. Advancements in implant design, surface modifications, and therapeutic approaches are driving market expansion, with a focus on improving long-term implant success rates and reducing complications such as infection and bone loss.

The dental clinics segment is expected to have the highest CAGR during the forecast period

The dental clinics segment is expected to have the highest CAGR during the extrapolated period. Dental clinics are increasingly adopting advanced diagnostic tools and treatment techniques, including laser therapy, antimicrobial agents, and regenerative procedures, to manage peri-implantitis. The growing awareness of implant failure risks and the need for effective interventions are driving demand for specialized treatments in these settings, fostering market growth.

Region with largest share:

North America region is estimated to account for the largest market share during the forecast period due to the rising number of dental implants. Advances in diagnostic and therapeutic technologies, including laser treatments and regenerative techniques, are driving the market. The region's well-established healthcare infrastructure, along with a high demand for dental care services, supports the market's expansion, positioning the region as a key hub for peri-implantitis treatment innovations.

Region with highest CAGR:

Asia Pacific is expected to register the highest growth rate over the forecast period driven by increasing oral health issues, rising awareness, and supportive healthcare policies. The prevalence of dental caries and periodontal disease is alarmingly high in the region, particularly among older adults. There is a growing awareness regarding oral health, which is crucial for driving demand for peri-implantitis treatments. Moreover, Favorable government policies and advancements in healthcare infrastructure are also contributing to market expansion.

Key players in the market

Some of the key players in Peri-Implantitis Treatment market include Pfizer Inc., Cadila Pharmaceuticals, R N. Laboratories, Triveni Chemicals, Arthrex, Zimmer Biomet Dental, Stryker, Smith & Nephew, Danaher, 3M, Meyer Dental Laboratory, Cochlear Limited, Medtronic, Bicon Dental Implants, Cendres+Metaux, Straumann AG and Fotona.

Key Developments:

In July 2024, Fotona announced the opening of the Laser & Health (LA&HA) Academy Training Center in Malaysia. Designed to support all Fotona users and practitioners, the new center aims to enhance knowledge, foster collaboration, and achieve clinical excellence.

In February 2024, Straumann has announced the complete acquisition of GalvoSurge, a Swiss medical device company specializing in dental implant care and maintenance solutions. GalvoSurge has developed an innovative approach to support peri-implantitis treatment, with its CE-marked device launched in 2020.

Treatment Types Covered:

  • Non-Surgical Treatments
  • Surgical Treatments
  • Combination Treatments
  • Other Treatment Types

Cause Types Covered:

  • Bacterial Infection
  • Excessive Occlusal Loading
  • Implant Design or Placement Issues
  • Biological

Implant Types Covered:

  • Titanium Implants
  • Zirconia Implants
  • Ceramic Implants
  • Hydroxyapatite Coatings
  • Polymer-Based Implants

Device Types Covered:

  • Ultrasonic Devices
  • Lasers
  • Bone Grafting Materials
  • Surgical Instruments

End Users Covered:

  • Dental Clinics
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Peri-Implantitis Treatment Market, By Treatment Type

  • 5.1 Introduction
  • 5.2 Non-Surgical Treatments
    • 5.2.1 Mechanical Debridement
    • 5.2.2 Laser Therapy
    • 5.2.3 Antimicrobial Therapy
    • 5.2.4 Local Drug Delivery
  • 5.3 Surgical Treatments
    • 5.3.1 Flap Surgery
    • 5.3.2 Bone Grafting
    • 5.3.3 Guided Bone Regeneration (GBR)
  • 5.4 Combination Treatments
  • 5.5 Other Treatment Types

6 Global Peri-Implantitis Treatment Market, By Cause Type

  • 6.1 Introduction
  • 6.2 Bacterial Infection
  • 6.3 Excessive Occlusal Loading
  • 6.4 Implant Design or Placement Issues
  • 6.5 Biological

7 Global Peri-Implantitis Treatment Market, By Implant Type

  • 7.1 Introduction
  • 7.2 Titanium Implants
  • 7.3 Zirconia Implants
  • 7.4 Ceramic Implants
  • 7.5 Hydroxyapatite Coatings
  • 7.6 Polymer-Based Implants

8 Global Peri-Implantitis Treatment Market, By Device Type

  • 8.1 Introduction
  • 8.2 Ultrasonic Devices
  • 8.3 Lasers
  • 8.4 Bone Grafting Materials
  • 8.5 Surgical Instruments

9 Global Peri-Implantitis Treatment Market, By End User

  • 9.1 Introduction
  • 9.2 Dental Clinics
  • 9.3 Hospitals
  • 9.4 Ambulatory Surgical Centers (ASCs)
  • 9.5 Other End Users

10 Global Peri-Implantitis Treatment Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Pfizer Inc.
  • 12.2 Cadila Pharmaceuticals
  • 12.3 R N. Laboratories
  • 12.4 Triveni Chemicals
  • 12.5 Arthrex
  • 12.6 Zimmer Biomet Dental
  • 12.7 Stryker
  • 12.8 Smith & Nephew
  • 12.9 Danaher
  • 12.10 3M
  • 12.11 Meyer Dental Laboratory
  • 12.12 Cochlear Limited
  • 12.13 Medtronic
  • 12.14 Bicon Dental Implants
  • 12.15 Cendres+Metaux
  • 12.16 Straumann AG
  • 12.17 Fotona

List of Tables

  • Table 1 Global Peri-Implantitis Treatment Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Peri-Implantitis Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 3 Global Peri-Implantitis Treatment Market Outlook, By Non-Surgical Treatments (2022-2030) ($MN)
  • Table 4 Global Peri-Implantitis Treatment Market Outlook, By Mechanical Debridement (2022-2030) ($MN)
  • Table 5 Global Peri-Implantitis Treatment Market Outlook, By Laser Therapy (2022-2030) ($MN)
  • Table 6 Global Peri-Implantitis Treatment Market Outlook, By Antimicrobial Therapy (2022-2030) ($MN)
  • Table 7 Global Peri-Implantitis Treatment Market Outlook, By Local Drug Delivery (2022-2030) ($MN)
  • Table 8 Global Peri-Implantitis Treatment Market Outlook, By Surgical Treatments (2022-2030) ($MN)
  • Table 9 Global Peri-Implantitis Treatment Market Outlook, By Flap Surgery (2022-2030) ($MN)
  • Table 10 Global Peri-Implantitis Treatment Market Outlook, By Bone Grafting (2022-2030) ($MN)
  • Table 11 Global Peri-Implantitis Treatment Market Outlook, By Guided Bone Regeneration (GBR) (2022-2030) ($MN)
  • Table 12 Global Peri-Implantitis Treatment Market Outlook, By Combination Treatments (2022-2030) ($MN)
  • Table 13 Global Peri-Implantitis Treatment Market Outlook, By Other Treatment Types (2022-2030) ($MN)
  • Table 14 Global Peri-Implantitis Treatment Market Outlook, By Cause Type (2022-2030) ($MN)
  • Table 15 Global Peri-Implantitis Treatment Market Outlook, By Bacterial Infection (2022-2030) ($MN)
  • Table 16 Global Peri-Implantitis Treatment Market Outlook, By Excessive Occlusal Loading (2022-2030) ($MN)
  • Table 17 Global Peri-Implantitis Treatment Market Outlook, By Implant Design or Placement Issues (2022-2030) ($MN)
  • Table 18 Global Peri-Implantitis Treatment Market Outlook, By Biological (2022-2030) ($MN)
  • Table 19 Global Peri-Implantitis Treatment Market Outlook, By Implant Type (2022-2030) ($MN)
  • Table 20 Global Peri-Implantitis Treatment Market Outlook, By Titanium Implants (2022-2030) ($MN)
  • Table 21 Global Peri-Implantitis Treatment Market Outlook, By Zirconia Implants (2022-2030) ($MN)
  • Table 22 Global Peri-Implantitis Treatment Market Outlook, By Ceramic Implants (2022-2030) ($MN)
  • Table 23 Global Peri-Implantitis Treatment Market Outlook, By Hydroxyapatite Coatings (2022-2030) ($MN)
  • Table 24 Global Peri-Implantitis Treatment Market Outlook, By Polymer-Based Implants (2022-2030) ($MN)
  • Table 25 Global Peri-Implantitis Treatment Market Outlook, By Device Type (2022-2030) ($MN)
  • Table 26 Global Peri-Implantitis Treatment Market Outlook, By Ultrasonic Devices (2022-2030) ($MN)
  • Table 27 Global Peri-Implantitis Treatment Market Outlook, By Lasers (2022-2030) ($MN)
  • Table 28 Global Peri-Implantitis Treatment Market Outlook, By Bone Grafting Materials (2022-2030) ($MN)
  • Table 29 Global Peri-Implantitis Treatment Market Outlook, By Surgical Instruments (2022-2030) ($MN)
  • Table 30 Global Peri-Implantitis Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 31 Global Peri-Implantitis Treatment Market Outlook, By Dental Clinics (2022-2030) ($MN)
  • Table 32 Global Peri-Implantitis Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 33 Global Peri-Implantitis Treatment Market Outlook, By Ambulatory Surgical Centers (ASCs) (2022-2030) ($MN)
  • Table 34 Global Peri-Implantitis Treatment Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.